Twitter

Archive for the ‘Cancer Clinical Trials’ Category


Dietary Intervention for Patients Receiving Chemoradiotherapy for Lung Cancer

In this phase I clinical trial, patients with advanced non-small cell lung cancer who are about to undergo chemoradiation therapy will consume a very low-carbohydrate ketogenic diet for the duration of their treatment.

Read More...

Dietary Intervention for Patients Receiving Chemoradiotherapy for Lung Cancer

In this phase I clinical trial, patients with advanced non-small cell lung cancer who are about to undergo chemoradiation therapy will consume a very low-carbohydrate ketogenic diet for the duration of their treatment.

Read More...

Comparing Relaxation Programs for Breast Cancer Patients Receiving Radiotherapy

In this study, women with breast cancer who have had surgery and are scheduled to undergo radiation therapy will be randomly assigned to one of two different stretching and relaxation programs or to a control group that will receive usual care.

Read More...

BI 836858 Dose Escalation in Refractory or Relapsed Acute Myeloid Leukemia

Condition :   Leukemia, Myeloid, Acute Intervention :   Drug: BI 836858 Sponsors :   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals Recruiting – verified September 2012

Read More...

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

Conditions :   Hepatocellular Carcinoma;   Portal Vein Thrombosis;   Hepatic Portal Vein Tumor Invasion Intervention :   Sponsors :   Hospital Sirio-Libanes;   Hospital Sirio-Libanes Recruiting – verified September 2012

Read More...

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT

Condition :   Multiple Myeloma Intervention :   Other: ACT PET/CT Sponsors :   Chang Gung Memorial Hospital;   Chang Gung Memorial Hospital Recruiting – verified September 2012

Read More...

Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies

Condition :   Cancer Intervention :   Drug: Nerofe Sponsors :   Immune System Key Ltd;   Immune System Key Ltd Not yet recruiting – verified September 2012

Read More...

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Condition :   Ovarian Cancer Interventions :   Drug: Veliparib;   Drug: Topotecan Sponsors :   Vejle Hospital;   Vejle Hospital;   Abbott Not yet recruiting – verified September 2012

Read More...

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Condition :   Metastatic Renal Cell Carcinoma Intervention :   Drug: Technetium Tc 99m EC20 Sponsors :   Endocyte;   Endocyte Completed – verified September 2012

Read More...

Nilotinib-Chemotherapy in CML Myeloid BC or Bcr-abl(+) AML

Conditions :   Chronic Myeloid Leukemia in Myeloid Blast Crisis;   Untreated Adult Acute Myeloid Leukemia Intervention :   Drug: Nilotinib+AD induction Sponsors :   Ulsan University Hospital;   Ulsan University Hospital;   The Korean Society of Hematology CML working party Recruiting – verified September 2012

Read More...